Imaging the Invisible: Granzyme B and the Future of Immunotherapy Monitoring with Guest Dr. Ben Larimer
Fractals: Life Science Conversations
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As a scientist, innovator, and CEO of CytoSite BioPharma, Dr. Ben Larimer has reshaped how we think about imaging immune response in cancer. His work on Granzyme B PET imaging is unlocking unprecedented insights into whether—and where—immunotherapies are working inside the body.
In this episode of Fractals, Ben joins host Colin Miller to discuss:
- The origins of Granzyme B imaging and what makes it a uniquely powerful imaging agent.
- How CytoSite’s imaging agent revealed success in preclinical models—and sparked a new clinical path forward.
- The balance between scientific innovation and real-world biotech execution.
- Why PET imaging’s future depends on AI, cost reduction, and deeper diagnostic precision.
Tune into Fractals: Life Science Conversations wherever you get your podcasts—and contact Bracken to learn how we help imaging agents move from molecule to market.